These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36280137)

  • 21. Medical cannabis and cannabinoids in rheumatology: where are we now?
    Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
    [No Abstract]   [Full Text] [Related]  

  • 22. The Anti-Inflammatory Effects of
    Zaiachuk M; Suryavanshi SV; Pryimak N; Kovalchuk I; Kovalchuk O
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins.
    Tubaro A; Giangaspero A; Sosa S; Negri R; Grassi G; Casano S; Della Loggia R; Appendino G
    Fitoterapia; 2010 Oct; 81(7):816-9. PubMed ID: 20450962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.
    Maayah ZH; Takahara S; Ferdaoussi M; Dyck JRB
    Inflamm Res; 2020 Jun; 69(6):549-558. PubMed ID: 32239248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical cannabis: Critical points for clinical application.
    Gómez-García DM; García-Perdomo HA
    Biomedica; 2022 Sep; 42(3):450-459. PubMed ID: 36122285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes.
    Modaresi F; Talachian K
    Pharmaceut Med; 2022 Dec; 36(6):387-400. PubMed ID: 36357543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
    Hasenoehrl C; Storr M; Schicho R
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of cannabis based treatment in Crohn's disease.
    Naftali T
    Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):253-257. PubMed ID: 32149543
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic potential of cannabinoids in combination cancer therapy.
    Malhotra P; Casari I; Falasca M
    Adv Biol Regul; 2021 Jan; 79():100774. PubMed ID: 33422460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoids in clinical practice.
    Williamson EM; Evans FJ
    Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Neurotherapeutic Arsenal in
    Al-Khazaleh AK; Zhou X; Bhuyan DJ; Münch GW; Al-Dalabeeh EA; Jaye K; Chang D
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Cavalheiro EKFF; Costa AB; Salla DH; Silva MRD; Mendes TF; Silva LED; Turatti CDR; Bitencourt RM; Rezin GT
    Cannabis Cannabinoid Res; 2022 Apr; 7(2):135-151. PubMed ID: 34242511
    [No Abstract]   [Full Text] [Related]  

  • 36. Phytocannabinoids: Origins and Biosynthesis.
    Gülck T; Møller BL
    Trends Plant Sci; 2020 Oct; 25(10):985-1004. PubMed ID: 32646718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies.
    Vimal D; D'Souza LC; Rai V; Lal S; Sharma A; Gupta SC
    Curr Med Chem; 2023; 30(2):178-202. PubMed ID: 35619266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis as a Source of Approved Drugs: A New Look at an Old Problem.
    Gabarin A; Yarmolinsky L; Budovsky A; Khalfin B; Ben-Shabat S
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.
    Botsford SL; Yang S; George TP
    Am J Addict; 2020 Jan; 29(1):9-26. PubMed ID: 31577377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoids: for better and for worse
.
    Thibaut F; Hoehe MR
    Dialogues Clin Neurosci; 2020 Sep; 22(3):201-204. PubMed ID: 33162763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.